These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1116 related articles for article (PubMed ID: 3127479)

  • 1. Monoclonal antibody against human tyrosinase and reactive with melanotic and amelanotic melanoma cells.
    McEwan M; Parsons PG; Moss DJ
    J Invest Dermatol; 1988 Apr; 90(4):515-9. PubMed ID: 3127479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody against a melanosomal protein in melanotic and amelanotic human melanoma cells.
    McEwan M; Parsons PG; Moss DJ; Burrows S; Stenzel D; Bishop CJ; Strutton GM
    Pigment Cell Res; 1989; 2(1):1-7. PubMed ID: 2470076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies produced against murine tyrosinase identify pigmented human melanocytes.
    Tomita Y; Hearing VJ
    Diagn Immunol; 1986; 4(3):149-54. PubMed ID: 3089671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-T4-tyrosinase monoclonal antibodies--specific markers for pigmented melanocytes.
    Tomita Y; Montague PM; Hearing VJ
    J Invest Dermatol; 1985 Nov; 85(5):426-30. PubMed ID: 2414367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of tyrosinase levels in amelanotic and melanotic melanoma cell cultures by a competitive enzyme-linked immunoadsorbent assay and by immunotitration analysis.
    Fuller BB; Iman DS; Lunsford JB
    J Cell Physiol; 1988 Jan; 134(1):149-54. PubMed ID: 3121644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of tyrosinase inhibitors and their differential action on melanogenic subcellular compartments in amelanotic and melanomas.
    Imokawa G; Mishima Y
    Br J Dermatol; 1980 Dec; 103(6):625-33. PubMed ID: 6779849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfer of tyrosinase to melanosomes in Harding-Passey mouse melanoma.
    Tomita Y; Hariu A; Kato C; Seiji M
    Arch Biochem Biophys; 1983 Aug; 225(1):75-85. PubMed ID: 6412634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of mouse tyrosinase with a monoclonal antibody MAT-1 against human tyrosinase.
    Suzuki S; Takimoto H; Masui S; Kato T; Shibata K; Tomita Y; Shibahara S; Nakano H
    Pigment Cell Res; 1996 Dec; 9(6):298-303. PubMed ID: 9125753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunophenotyping of melanomas for tyrosinase: implications for vaccine development.
    Chen YT; Stockert E; Tsang S; Coplan KA; Old LJ
    Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8125-9. PubMed ID: 7667256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammalian monophenol monooxygenase (tyrosinase): purification, properties, and reactions catalyzed.
    Hearing VJ
    Methods Enzymol; 1987; 142():154-65. PubMed ID: 3110555
    [No Abstract]   [Full Text] [Related]  

  • 11. MAT-1, a monoclonal antibody that specifically recognizes human tyrosinase.
    Takimoto H; Suzuki S; Masui S; Shibata K; Tomita Y; Shibahara S; Nakano H
    J Invest Dermatol; 1995 Dec; 105(6):764-8. PubMed ID: 7490469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of pigmentation in mouse fibroblasts by expression of human tyrosinase cDNA.
    Bouchard B; Fuller BB; Vijayasaradhi S; Houghton AN
    J Exp Med; 1989 Jun; 169(6):2029-42. PubMed ID: 2499655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical characterization of three hamster melanoma variants--I. Tyrosinase activity and melanin content.
    Słomiński A; Scisłowski PW; Bomirski A
    Int J Biochem; 1984; 16(3):323-6. PubMed ID: 6421636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosinase activity in primary cell culture of amelanotic melanoma cells.
    Słomiński A; Scisłowski PW; Bomirski A
    Biosci Rep; 1983 Nov; 3(11):1027-34. PubMed ID: 6140964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microheterogeneity of melanosome-bound tyrosinase from the Harding-Passey murine melanoma.
    Ferrini U; Mileo AM; Hearing VJ
    Int J Biochem; 1987; 19(3):227-34. PubMed ID: 3109972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells.
    Halaban R; Cheng E; Zhang Y; Moellmann G; Hanlon D; Michalak M; Setaluri V; Hebert DN
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6210-5. PubMed ID: 9177196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular localization of tyrosinase in human malignant melanoma cell lines.
    Foa C; Aubert C
    J Invest Dermatol; 1977 Jun; 68(6):369-78. PubMed ID: 405430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific inhibition by antityrosinase antibodies of tyrosinase-mediated melanogenesis.
    Vachtenheim J; Duchon J; Matous B; Vulterin K
    J Invest Dermatol; 1986 May; 86(5):573-6. PubMed ID: 3091707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of tyrosinase to homogeneity based on its resistance to sodium dodecyl sulfate-proteinase K digestion.
    Yurkow EJ; Laskin JD
    Arch Biochem Biophys; 1989 Nov; 275(1):122-9. PubMed ID: 2510599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophoretic profile of tyrosinase treated with neuraminidase in various subcellular fractions from mouse melanoma.
    Tomita Y; Moro S; Seiji M
    J Dermatol; 1979 Apr; 6(2):125-7. PubMed ID: 112132
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 56.